Juvenile neuronal ceroid lipofuscinosis (jNCL) is a rare but fatal inherited lysosomal storage disorder mainly affecting children. The disease is caused by mutations in the CLN3 gene that lead to the accumulation of storage material in many tissues, prominent immune responses and neuronal degeneration. One of the first symptoms is vision loss followed by motor dysfunction and mental decline. The established Cln3Δex7/8 mouse model mimics many pathological features of the human disease except the retinal phenotype, which is very mild and occurs only very late in these mice. Here, we first carefully analyzed the retinal structure and microglia responses in these animals. While prominent autofluorescent spots were present in the fundus, only a moderate reduction of retinal thickness and no prominent microgliosis was seen in young CLN3-deficient mice. We next genetically introduced a light-sensitive RPE65 variant and established a light-damage paradigm that showed a high susceptibility of young Cln3Δex7/8 mice after exposure to 10,000 lux bright light for 30 min. Under these ‘low light’ conditions, CLN3-deficient mice showed a strong retinal degeneration, microglial activation, deposition of autofluorescent material and transcriptomic changes compared to wild-type animals. Finally, we treated the light-exposed Cln3Δex7/8 animals with the immunomodulatory compound minocycline, and thereby rescued the retinal phenotype and diminished microgliosis. Our findings indicate that exposure to specific light conditions accelerates CLN3-dependent retinal degeneration, and that immunomodulation by minocycline could be a possible treatment option to delay vision loss in jNCL patients.
This article has an associated First Person interview with the first author of the paper.
Neuronal ceroid lipofuscinoses (NCLs) are a group of rare autosomal recessive lysosomal storage diseases mainly affecting children, with incidence rates between 1.3 and 7 per 100,000 live births (Mole et al., 2011). The most common form is the juvenile subtype (jNCL), affecting children between 5 and 10 years of age. The first symptom is vision loss, followed by mental deterioration, seizures, immune system abnormalities, personality changes and loss of motor abilities resulting in early death in the twenties (Birch, 1999; Castaneda and Pearce, 2008; Schulz et al., 2013; Staropoli et al., 2012). The underlying genetic defects are characterized by mutations in the CLN3 gene, which encodes the CLN3 protein (also called battenin), a broadly expressed lysosomal transmembrane protein. The most frequent mutation, occurring in over 80% of patients, is the deletion of exons 7 and 8, resulting in a truncated dysfunctional protein (Cotman et al., 2002; Mole and Cotman, 2015).
Several studies have implicated a role for CLN3 in autophagy, endocytosis, synapse formation, intracellular trafficking, calcium homeostasis and regulation of lysosomal pH (An Haack et al., 2011; Cao et al., 2006; Golabek et al., 2000; Lojewski et al., 2014; Luiro et al., 2004, 2001; Uusi-Rauva et al., 2012). Malfunction of the CLN3 protein leads to accumulation of lysosomal storage material, with accumulations mainly composed of subunit c of the mitochondrial ATP synthase (SubC), lipoproteins and glycoproteins (Palmer et al., 1992; Staropoli et al., 2012).
A typical hallmark of neuronal degeneration is microglial reactivity. Microglia are the resident cells of the innate immune system in the central nervous system (CNS). In the healthy retina, they are located in the plexiform layers, and have a typical ramified morphology with small somata and long, branched protrusions (Hume et al., 1983). They continuously scan their environment for changes in neuronal homeostasis (Nimmerjahn et al., 2005). Dying cells can be recognized by a variety of receptors and ligands, leading to a morphological change of microglial cells to an amoeboid shape. Thereby, microglia migrate towards the area of damage and phagocytose debris. Depending on the nature and duration of the stimulus, a chronic activation can occur. As a result, microglial cells show an increased expression of pro-inflammatory mediators and phagocytose healthy photoreceptor cells, leading to damage of the surrounding neuronal tissue (Aslanidis et al., 2015; Kettenmann et al., 2011; Zhao et al., 2015). Microglia activation is often detected before the first signs of neuronal cell death, leading to the hypothesis that early microglial activation may promote the degenerative disease progression (Karlstetter et al., 2010; Langmann, 2007; Pontikis et al., 2004; Schuetz and Thanos, 2004).
Only a few reports have studied the role of glial cells in jNCL pathogenesis. CLN3 deficiency leads to a functional impairment of microglia and a higher sensitivity of neuronal cells to neurotoxic substances in vitro (Parviainen et al., 2017; Xiong and Kielian, 2013). Microglia colocalization with neurons expressing high amounts of an antioxidant enzymes was shown in a Cln3−/− mouse model (Benedict et al., 2007). Additionally, accumulation of autofluorescent material and an upregulation of glial fibrillary acid protein (GFAP) was seen in human retinal cross-sections with CLN3 deficiency (Bensaoula et al., 2000). These findings led to the hypothesis that microglial activation is connected to neuronal cell damage via oxidative stress (Benedict et al., 2007). Furthermore, microglial activation, storage of autofluorescent material, neuronal death and retinal thinning was observed in the jNCL mouse model at 17 months (Cotman et al., 2002; Pontikis et al., 2004; Seigel et al., 2002). Recently, it was shown that treatment with an autophagy enhancer reduced gliosis in old CLN3-deficient mice (Palmieri et al., 2017).
Different jNCL models were created and used to clarify the pathological mechanisms of CLN3 dysfunction and potential treatments, including cell lines, yeast, amoeba and genetically modified mice (Cotman et al., 2002; Fossale et al., 2004; Gachet et al., 2005; Huber et al., 2016; Mitchison et al., 1999). The most commonly studied and widely accepted jNCL model is a knock-in mouse carrying a deletion of exons 7 and 8 in the Cln3 gene, representing the same genetic defect found in over 80% of patients (Cotman et al., 2002). The homozygous Cln3Δex7/8 mouse recapitulates many pathological features observed in jNCL patients, with the exception of the early retinal degeneration and vision loss commonly found in jNCL children (Staropoli et al., 2012).
To better simulate the human jNCL condition, we adapted a model of rapid light-induced retinal degeneration in the Cln3Δex7/8 mouse model after introducing the light-sensitive variant of the retinal pigment epithelium-specific 65 kDa protein (RPE65), a genetic modification that is necessary to increase sensitivity to light stress. After finding a jNCL-specific light sensitivity threshold, we tested the effects of the immunomodulatory compound minocycline on microglial reactivity and retinal degeneration. Our data showed that minocycline inhibited microglial responses and significantly delayed retinal degeneration in Cln3Δex7/8 animals, implicating a potential therapeutic use of targeting the immune system in jNCL patients to delay vision loss.
CLN3-deficient retinas show only weak retinal thinning but display autofluorescent material in microglia
We first examined whether young Cln3Δex7/8 mice carrying the light-sensitive Rpe65 leucine variant show structural retinal alterations compared to control animals. In vivo imaging using spectral domain optical coherence tomography (SD-OCT) identified only a minor thinning of CLN3-deficient retinas compared to wild-type littermates (Fig. 1A, top and middle panels). As accumulation of autofluorescent material is a hallmark of jNCL, we next analyzed the retinal fundus using the BAF (BluePeak Blue laser autofluorescence) method. Evenly distributed autofluorescent spots that were absent in wild-type eyes appeared in the Cln3Δex7/8 retinas (Fig. 1A, bottom panels). To evaluate this in more detail, we analyzed retinal cryosections (Fig. 1B) and flat mounts (Fig. 1C) with immunostainings. We first stained retinal sections with antibodies against Iba1 and translocator protein 18 kDa (TSPO), two markers for ramified and activated microglia, respectively (Lückoff et al., 2016) (Fig. 1B). These data showed the normal appearance of microglia in the plexiform layers and no prominent signs of microglia reactivity in Cln3Δex7/8 retinas compared to littermates (Fig. 1B). Staining for GFAP also revealed only minor features of gliosis (Fig. 1B). We then analyzed mitochondrial ATPase (SubC) as one of the characteristic storage materials found in tissue of jNCL patients. These analyses observed enrichment of SubC within the inner segments of the photoreceptor cells (IS), the inner nuclear layer (INL) and to a lesser extent in the ganglion cell layer (GCL) of CLN3-deficient mice, but not in wild-type littermates (Fig. 1B, bottom panels).
Additional staining of cryosections for cathepsin D (CatD), a marker known to be differentially expressed in CLN3 dysfunction, revealed low CatD expression in the IS, INL and GCL in the aged wild-type retina but increased expression in the aged Cln3Δex7/8 retina with a clustered appearance (Fig. S1A) (Fossale et al., 2004; Golabek et al., 2000). In young animals, higher CatD expression was only noticed in the light-damaged Cln3Δex7/8 retina (Fig. S1B).
Further analyses of autofluorescence and Iba1 localization in retinal flat mounts then showed accumulation of autofluorescent material in microglial somata of CLN3-deficient animals (Fig. 1C). We therefore postulate that microglia somata enriched with lipids appear as autofluorescent spots in the fundus analysis (Fig. 1A).
CLN3-deficient retinas are highly susceptible to light damage
Given the very mild retinal degeneration in young Cln3Δex7/8 mice, we sought to establish a light-damage paradigm that could distinguish CLN3-deficient animals from controls. Cln3Δex7/8 mice and their wild-type littermates, both carrying a light-sensitive Rpe65 gene variant, were then exposed to two different light intensities, a ‘low light’ condition with 10,000 lux for 30 min and a ‘high light’ condition with 15,000 lux for 60 min. Animals that were not exposed to bright white light served as controls. Retinal thickness was then determined at 1, 4 and 7 days after light exposure using in vivo ocular imaging. SD-OCT thickness maps of CLN3-deficient mice showed a much stronger retinal thinning under ‘low light’ conditions compared to wild-type mice (Fig. 2A, blue, middle panels). In contrast, ‘high light’ conditions indicated retinal damage in both strains (Fig. 2A, right panels). Quantification of these SD-OCT thickness maps revealed a highly significant retinal thinning (P<0.001) for Cln3Δex7/8 animals at a light exposure of 10,000 lux for 30 min at days 4 and 7 (Fig. 2B). In contrast, wild-type mice showed no retinal thinning after exposure to these ‘low light’ conditions (Fig. 2B). As both wild-type and Cln3Δex7/8 animals displayed significant retinal thinning at ‘high light’ conditions, we defined an exposure to 10,000 lux for 30 min as the jNCL-specific threshold for light damage.
We then evaluated whether exposure to bright white light leads to changes in the amount of autofluorescent material (Fig. 3). Storage material was observed in CLN3-deficient retinas under both ‘low light’ and ‘high light’ conditions (Fig. 3A, left panels), whereas autofluorescent material appeared in wild-type retinas only under ‘high light’ conditions (Fig. 3A, right panels). Quantification of the autofluorescent area revealed significant differences between Cln3Δex7/8 mice and control animals when applying ‘low light’ conditions at day 4 and day 7 (Fig. 3B). No significant differences were identified between wild-type and CLN3-deficient retinas under ‘high light’ conditions.
Microgliosis and accumulation of autofluorescent material in CLN3-deficient retinas at ‘low light’ conditions
We next analyzed microgliosis in retinas exposed to either light condition. Iba1 staining of cryosections showed microglia migration towards the outer retina starting at day 4 in ‘low light’-exposed CLN3-deficient mice but not in wild-type mice (Fig. 4, left panels). Accumulation of autofluorescent material was also detected at these time points, which are known as peaks of microgliosis (Lückoff et al., 2016). Microgliosis was seen in both wild-type and CLN3-deficient retinas under ‘high light’ conditions (Fig. 4, right panels). Concurrent Iba1-stained flat mounts verified a higher number of microglia in the subretinal space of CLN3-deficient animals exposed to ‘low light’ conditions, compared to controls (Fig. 5A, left panels). Quantification then showed an increase in the Iba1-positive area (Fig. 5B), the total number of microglial cells (Fig. 5C) and the autofluorescent area (Fig. 5D) in battenin-deficient retinas compared to wild-type tissue. No significant differences were observed between wild-type and CLN3-deficient retinas at ‘high light’ conditions (Fig. 5A, right panels; Fig. 5B-D). This difference in gliosis between CLN3-deficient and wild-type mice exposed to ‘low light’ conditions was also seen with a stronger expression of TSPO (Fig. S2) and GFAP (Fig. S3) in cryosections of Cln3Δex7/8 animals.
To assess the expression of pro-inflammatory mediators, we then measured gene expression of the microgliosis markers activated microglia/macrophage whey acidic protein (AMWAP), TSPO and CD68 using quantitative real-time PCR (qRT-PCR) 4 days after light exposure (Fig. S4). All three markers showed a significant increase in CLN3-deficient retinas exposed to ‘low light’ conditions compared to wild-type retinas. Notably, upregulation of TSPO and CD68 was even detected in CLN3-deficient retinas not exposed to light (Fig. S4B,C).
Further analysis of SubC revealed increased amounts in CLN3-deficient retinas, whereas wild-type retinas only showed SubC deposits at ‘high light’ conditions at day 7 (Fig. S5). Staining of CatD in retinal cryosections of ‘low light’-exposed Cln3Δex7/8 mice and ‘high light’-exposed wild-type mice revealed a cluster-like appearance similar to the CatD distribution in the aged CLN3-deficient animals (Fig. S1B, bottom images).
Transcriptomic effects of light stress in CLN3-deficient retinas mirror disease-specific patterns
We next evaluated whether the ‘low light’ exposure conditions elicit jNCL-specific changes in Cln3Δex7/8 mice that are different from wild-type responses. Therefore, we performed a global gene expression analysis using DNA microarrays. Gene expression dynamics inspector (GEDI) analysis that creates self-organizing maps by ‘gestalt’ recognition (Eichler et al., 2003) showed prominent but different clusters of light-dependent changes in wild-type mice (Fig. S6A) and Cln3Δex7/8 mice (Fig. S6B). In Cln3Δex7/8 retinas, ‘low light’ conditions influenced two major gene clusters that were either reduced (Fig. S6B, top rectangles) or induced (Fig. S6B, bottom rectangles). An in-depth analysis of the transcripts in these clusters revealed 522 significantly upregulated and 623 downregulated genes in light-triggered CLN3-deficient retinas (Fig. S7A). Further comparisons of these dysregulated genes in light-damaged Cln3Δex7/8 mice with the light-regulated transcriptome of wild-type animals revealed 224 upregulated and 55 downregulated genes specifically present in CLN3-deficient retinas (Fig. S7B). Pathway analysis showed that these CLN3-specific transcriptomic changes were associated with different biochemical and cellular processes. However, the majority of the upregulated genes (39%) were associated with immune responses and more specifically were pro-inflammatory (Fig. S7C). The genes downregulated in Cln3Δex7/8 retinas under ‘low light’ conditions were found in several different pathways (Fig. S7B) and only a minor fraction was immune-related (Fig. S7C).
Minocycline therapy prevents retinal thinning and accumulation of autofluorescent material
We have previously shown that immunomodulation with minocycline has beneficial effects on retinal degeneration in the light-damage paradigm (Scholz et al., 2015). To test whether the susceptibility of CLN3-deficient mice to ‘low light’ conditions can be reduced by this form of therapy, animals were treated by intraperitoneal injection of minocycline (45 mg/kg body weight) or 0.9% sodium chloride solution daily, starting 1 day before light exposure. The SD-OCT thickness maps showed a greenish color for minocycline-treated animals compared to the blueish color from vehicle-treated animals (Fig. 6A). Quantification revealed a significant preservation of retinal thickness for minocycline-treated animals compared to vehicle-treated mice (Fig. 6B). These findings were confirmed by counting the rows of photoreceptor cell nuclei in DAPI-stained cryosection panoramas. The resulting spidergram analysis showed a significant preservation of photoreceptor cell nuclei in the central parts of the retina after minocycline treatment compared to vehicle-treated CLN3-deficient mice (Fig. 6C).
Furthermore, minocycline treatment prevented the accumulation of autofluorescent material in the retina (Fig. 7A). A significantly lower area of autofluorescent material was detected at 4 days and 7 days after light exposure in minocycline-treated retinas compared to vehicle-treated retinas (Fig. 7B). This suggests that minocycline efficiently prevents the light-induced photoreceptor loss in Cln3Δex7/8 animals.
Minocycline therapy prevents microglial reactivity in CLN3-deficient retinas
We next studied the effects of minocycline on microgliosis in light-exposed CLN3-deficient retinas. A strong microglial migration towards the subretinal space was observed in vehicle-treated retinas (Fig. 8A, middle panels). In contrast, only a minor migration of microglia was seen in minocycline-treated retinas (Fig. 8A, right panels). Additionally, Iba1-stained flat mounts showed reduced microglial occurrence in the subretinal space as well as a lower amount of autofluorescent material in the minocycline treatment group (Fig. 8B). Quantification of Iba1-positive area, number of microglial cells and the area of autofluorescent material showed significant reduction of all three analysis parameters in mice treated with minocycline compared to vehicle treatment (Fig. 8C-E).
In accordance with the data from microglia migration, lower expression of TSPO and GFAP was present in cryosections of minocycline-treated Cln3Δex7/8 mice compared to the vehicle-treated group (Fig. S8A,B). Furthermore, the increased accumulation of SubC observed in CLN3-deficient retinas after light exposure was reduced when animals were treated with minocycline (Fig. S8C).
Retinal qRT-PCR analysis of the pro-inflammatory markers AMWAP, CCL2 (CC-chemokine ligand 2), CD68, IL1β (interleukin 1β), TNFα (tumor necrosis factor α) and TSPO (translocator protein 18 kDa) measured 4 days after light exposure showed a significantly lower expression in minocycline-treated animals compared to vehicle-treated animals (Fig. S9).
Minocycline downregulates pro-inflammatory gene clusters
To evaluate whether minocycline treatment has an influence on the upregulated genes that were specifically found in light-damaged CLN3-deficient retinas, microarray datasets from light-exposed and minocycline-treated Cln3Δex7/8 mice were compared to light-exposed and vehicle-treated Cln3Δex7/8 mice. The GEDI maps showed lower expression of gene clusters arising under light-triggered conditions in CLN3-deficient mice (Fig. S6B, bottom right rectangles). Among these genes, 22 genes were significantly downregulated by minocycline administration (Fig. S10A) and the majority was associated with immune responses pathways (Fig. S10B). Finally, qRT-PCR was used to validate three immune-related genes that were specifically light-induced in Cln3Δex7/8 retinas and counter-balanced by minocycline. Apolipoprotein D (ApoD), interferon regulatory factor 7 (Irf7) and Z-DNA binding protein 1 (Zpb1) showed the expected patterns of regulation, similar to the profiles identified by DNA-microarrays (Fig. S11).
Chronic microglia reactivity and expression of neurotoxic substances are detrimental for the brain and the retina (Hanisch and Kettenmann, 2007; Langmann, 2007; Zhao et al., 2015). Since immune responses in the CNS occur in jNCL models at higher ages (Pontikis et al., 2004), we here analyzed microglial behavior in young CLN3-deficient mice. We saw no clear characteristics of inflammation and only a slight thinning of the retina in 8- to 10-week-old mice. Significant retinal thinning was present in another jNCL mouse, the Cln3−/− model, at 18 months (Groh et al., 2014). These CLN3-deficient mice also showed autofluorescent material in the fundus, verifying our data. Furthermore, accumulation of autofluorescent material was detected in neuronal tissue of jNCL patients (Bensaoula et al., 2000; Cotman et al., 2002). Here, we showed that microglia in Cln3Δex7/8 animals were correctly located in the plexiform layers, showed a ramified morphology, and had low expression of TSPO and GFAP. These findings are in line with the low neuronal immune responses described in another publications (Pontikis et al., 2004). Our data are in contrast to in vivo and ex vivo experiments describing altered brain microglia morphology and impaired behavior (Parviainen et al., 2017; Xiong and Kielian, 2013). A further hallmark of jNCL pathology is the accumulation of autofluorescent storage material composed of SubC, lipoproteins and glycoproteins, assumed to play the major role in neuronal cell death (Palmer et al., 1992). Here, accumulation of SubC was shown in cryosections of CLN3-deficient mice in all retinal layers. The distribution pattern of SubC stainings in our Cln3Δex7/8 animals was very similar to the pattern of autofluorescent material in Cln3−/− mice (Seigel et al., 2002).
Most other mouse models of NCL, including the Cln5−/− and Cln6nclf mouse, which mimics late-infantile NCL, display prominent retinal degeneration and microglia reactivity at younger ages (Bartsch et al., 2013; Leinonen et al., 2017; Mirza, 2013). Therefore, a major goal of this study was to experimentally modify the Cln3Δex7/8 model for jNCL so that it showed an earlier retinal phenotype, comparable to the human situation. Exposure to bright white light is a widely used model for retinal degeneration and microglial activation (Grimm and Remé, 2013). Therefore, it was necessary to genetically introduce a specific Rpe65 variant leading to light sensitivity of Cln3Δex7/8 mice by crossing with BALB/c animals (Samardzija et al., 2006). The resulting modified CLN3-deficient mice showed a higher susceptibility to white-light exposure than the original strain and, importantly, also compared to wild-type animals that were not susceptible to light exposure at 10,000 lux for 30 min. Under these ‘low light’ conditions, the genetically modified CLN3-deficient mice displayed a strong thinning of retinal layers and showed typical hallmarks for microgliosis. In vivo imaging and stainings also detected increased amounts of autofluorescent material in ‘low light’-exposed Cln3Δex7/8 animals, potentially reflecting increased autofluorescence observed in the fundus of early-stage jNCL patients (Kelly et al., 2009).
The question arises of whether the ‘low light’-induced early retinal degeneration in Cln3Δex7/8 mice recapitulated the retinal changes in jNCL patients. Our data support this hypothesis in several ways. First, besides the accumulation of SubC as discussed above, a dysregulation of the lysosomal enzyme CatD has been connected with the absence of CLN3 (Cárcel-Trullols et al., 2017; Fossale et al., 2004; Golabek et al., 2000; Kyttälä et al., 2006). Indeed, here we showed enrichment of CatD in ‘low light’-triggered retinal degeneration in young Cln3Δex7/8 mice that was normally only present in aged Cln3Δex7/8 mice. Second, the transcriptomic analysis showed light-dependent dysregulation of a high number of genes in Cln3Δex7/8 retinas that were not regulated in wild-type animals. We found a strong effect of retinal CLN3 deficiency on immune response pathways that was also previously noticed in total eye and cerebellum transcripts from young Cln3−/− mice (Chattopadhyay et al., 2004; Brooks et al., 2003). Of particular interest were those genes that were upregulated in light-triggered Cln3Δex7/8 animals compared to light-damaged wild-type mice and in turn downregulated with minocycline treatment. Irf7 and Zbp1, two genes that regulate immune responses and are associated with neuronal cell loss, are highly upregulated in CLN3-deficient and light-triggered mice, and are examples for a possible overshooting immune reaction already described for CLN3-deficient primary microglia (DeFilippis et al., 2010; Gao et al., 2017; Mustafi et al., 2012; Xiong and Kielian, 2013).
Minocycline is an approved clinical antibiotic drug that is also known to dampen microglial reactivity and prevent photoreceptor loss in several mouse models of neuronal degeneration (Du et al., 2001; Peng et al., 2014; Scholz et al., 2015; Zhao et al., 2011). Consistent with these reports, minocycline showed a protective effect on light-triggered microglial activation and retinal thinning in our modified CLN3-deficient mouse model. In vivo imaging in combination with immunohistochemical stainings showed a preservation of retinal thickness when CLN3-deficient mice were treated with minocycline during white-light damage. Additionally, minocycline administration reduced the accumulation of autofluorescent material in the subretinal space. This is probably due to reduced neuronal cell death and therefore less cellular debris. We found less microgliosis and lower expression of CD68 and IL-1β, which is in line with the published effects of minocycline in an ischemia-reperfusion model of retinal degeneration (Ahmed et al., 2017). In our CLN3-deficient mice, minocycline suppressed expression of the pro-inflammatory mediators AMWAP, TSPO and CCL2, which was previously demonstrated for wild-type mice under high-light conditions (Scholz et al., 2015).
The decreased expression of pro-inflammatory mediators in combination with preservation of photoreceptor cells and reduction of storage material leads to the assumption that minocycline administration mediates its effects mainly via immunomodulation. However, a study with orally treated CLN6-deficient sheep, a model for the late-infantile variant of NCL, with minocycline, could not dampen neuroinflammation in the brain (Kay and Palmer, 2013). The species differences and different forms of NCL may potentially explain the treatment success in our modified mouse retinal stress model and the disappointing findings from CLN6 South Hampshire sheep.
MATERIALS AND METHODS
Cln3Δex7/8 mice on a C57BL/6J background were a generous gift from S. Cotman (Cotman et al., 2002). To introduce the light-sensitive Rpe65 leucine variant in the strain, the mice were first crossed with wild-type BALB/c and then with C57BL/6J mice for five generations to obtain a homogenous genetic background. Resulting Cln3Δex7/8 mice, carrying the leucine variant of RPE65 on a C57BL/6J background, were genotyped to determine the presence of the Cln3Δex7/8 knock-in allele as previously described (Fossale et al., 2004). For the Rpe65 variant, a PCR fragment of 674 bp length was generated using the following primers: Rpe65_pos450_F (5′-CACTGTGGTCTCTGCTATCTTC-3′) and Rpe65_pos450_R (5′GGTGCAGTTCCATTCAGTT-3′) with PCR cycling conditions of 95°C for 30 s, 56°C for 30 s and 72°C for 35 s, repeated for 34 cycles. Amplicons were digested using MwoI to detect a specific restriction site at position 450, resulting in two fragments, of 236 and 437 bp, for the leucine variant or a 674 bp undigested fragment for the methionine variant (Wenzel et al., 2001). Mice were maintained in an air-conditioned environment with 12-h light-dark schedule with a maximum light intensity of 150 lux inside the cages. Water and food were given ad libitum. For this study, 8- to 10-week-old male and female animals were used. All experimental procedures were in compliance with the German law on animal protection and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The animal protocols used in this study were reviewed and approved by the governmental body responsible for animal welfare in the state of Nordrhein-Westfalen (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen, Germany; approval Nr 84-02.04.2017.A113).
Light exposure and minocycline administration
Wild-type littermates and Cln3Δex7/8 mice were dark-adapted for 16 h before light exposure. To test low-light and high-light conditions, pupils were dilated with 2.5% phenylephrin and 1% tropicamide under dim red light and the mice were placed into aluminum-foil-coated cages. A light intensity of 10,000 lux for 30 min for low-light conditions and a light intensity of 15,000 lux for 60 min for high-light conditions were used, respectively. Mice of both genotypes without light exposure served as controls. Then, mice were then kept in dark-reared conditions overnight. For the therapy study with minocycline only, Cln3Δex7/8 mice and low-light conditions were used. Minocycline (45 mg/kg body weight dissolved in 0.9% NaCl solution, Sigma) was injected intraperitoneally starting 1 day before light exposure and then daily until 1 day before the final experiment. Cln3Δex7/8 mice were injected with the same volume and frequency of 0.9% NaCl solution as a solvent control.
In vivo imaging using SD-OCT and BAF
SD-OCT and BAF images were taken at 1, 4 and 7 days after light exposure. After anesthetizing the mice by intraperitoneal injection of Rompun (10 mg/kg body weight) and Ketavet (100 mg/kg body weight), the pupils were dilated with 2.5% phenylephrin and 1% tropicamide. SD-OCT was performed on both eyes with a Spectralis™ HRA+OCT device (Heidelberg Engineering) to evaluate structural changes. Retinal thickness was analyzed using SD-OCT thickness maps calculated by the Heidelberg Eye Explorer Software. A mean for each eye was determined from the four quarters (circle diameter 3 ETDRS) around the optic nerve head, representing the average retinal thickness (µm) in a certain field. BAF imaging was conducted at day 1, 4 and 7 to assess autofluorescent material using a Spectralis™ HRA+OCT device (Heidelberg Engineering). Three images per condition were analyzed for quantification.
Immunohistochemistry and image analysis
For immunohistochemical analysis, eyes were enucleated at day 1, 4 and 7, and fixed in 4% formaldehyde for 2 h at room temperature. Eyes were dissected for retinal flat mounts or transferred into 30% sucrose overnight at room temperature (RT) before embedding in optimal cutting temperature (OCT) compound for cryosectioning. Sections of 12 µm thickness were rehydrated with PBS, blocked with dry milk solution and incubated with primary antibody solution. Flat mounts were permeabilized with 2.5% Triton X-100 and 2.5% Tween-20, blocked with dry milk solution and incubated in primary antibody solution. Specific antibodies against Iba1 (1:500, Wako Chemicals, Neuss, Germany; 1:500 donkey-anti goat, Abcam, Cambridge, UK), TSPO (1:250, Abcam), GFAP (1:400, Sigma, MO, USA) and SubC (1:250, Abcam) were used overnight at 4°C. Afterwards, flat mounts and sections were incubated with the appropriate secondary antibodies conjugated to Alexa Fluor 488 (Jackson Immuno-Research, West Grove, PA, USA) at RT for 1 h. Cryosections were counterstained with 4′,6-diamidino-2-phenylindol (DAPI). All samples were mounted with DAKO fluorescent mounting medium (Dako Deutschland GmbH, Hamburg, Germany) and analyzed with an AxioImager.M2 plus ApoTome2 microscope (Carl Zeiss). Iba1-positive area, number of microglia and area of autofluorescent material was evaluated by ImageJ. For this purpose, 24 images (20× magnification) of each eye were taken of three animals from three independent experiments and analyzed using FIJI software.
RNA was isolated from freshly dissected retinal tissue and transcribed to cDNA. A total of 25 ng cDNA was amplified using the RevertAid™ H-Minus First Strand cDNA Synthesis Kit (Fermentas, Germany). Amplification of 40 ng cDNA was performed on an ABI7900HT machine (Applied Biosystems, Carlsbad, CA, USA). Reaction mixtures contained 2.5 µl sample, 1× Fast Start Universal Probe Master (Rox; Roche Applied Science, Switzerland), 100 nM of primers and 0.125 μl of dual-labeled UPL probe (Roche). A setting of the following reaction parameters were used: 10 min 95°C hold, 40 cycles of 15 s 95°C melt, followed by 1 min 60°C anneal/extension. Used primers and probes were as followed: AMWAP, forward primer 5′-TTTGATCACTGTGGGGATGA-3′, reverse primer 5′-ACACTTTCTGGTGAAGGCTTG-3′, probe #1; ApoD, forward primer 5′-AATTTCCATCTTGGGAAATGC-3′, reverse primer 5′-GGATCTTCTCAATTTCGTACCATC-3′, probe #63; Atp5b, forward primer 5′-GGCACAATGCAGGAAAGG-3′, reverse primer 5′-TCAGCAGGCACATAGATAGCC-3′, probe #77; CCL2, forward primer 5′-CATCCACGTGTTGGCTCA-3′, reverse primer 5′-GATCATCTTGCTGGTGAATGAGT-3′, probe #62; CD68, forward primer 5′-CTCTCTAAGGCTACAGGCTGCT-3′, reverse primer 5′-TCACGGTTGCAAGAGAAACA-3′; probe #27, IL1β, forward primer 5′-TGTAATGAAAGACGGCACACC-3′, reverse primer 5′-TCTTCTTTGGGTATTGCTTGG-3′; probe #78, Irf7, forward primer 5′-CTTCAGCACTCCCTTCCGAGA-3′, reverse primer 5′-TGTAGTGTGGTGACCCTTGC-3′; probe #25, Zbp1, forward primer 5′-GCTGTGAGCATGGCAGAA-3, reverse primer 5′-CACCTGCAGGATCTTTTGCT-3′; probe #99, Tnfα, forward primer 5′-CTGTAGCCCACGTCGTAGC-3′, reverse primer 5′-TCTTCTTTGGGTATTGCTTGG-3′; TSPO, forward primer 5′-ACTGTATTCAGCCATGGGGTA-3′, reverse primer 5′-ACCATAGCGTCCTCTGTGAAA-3′, probe #33. Measurements were performed in technical duplicates. ATP5B expression was used as reference gene and resulting values were calculated using the ΔΔCt method for relative quantification.
DNA microarrays and bioinformatic data analysis
Duplicate microarrays were carried out with two independent RNAs and procedures involving preparation and labeling of cRNA, hybridization to Affymetrix 430 2.0 mouse genome arrays, washing and scanning were performed according to the standard protocol. The cut-off applied for genes considered to be differentially expressed was a log2 fold change of ≥2 or ≤−2 and a P<0.05. Integrative analysis of genome-wide expression activities was performed with the Gene Expression Dynamics Inspector (GEDI), a MatLab (MathWorks, Natick, MA, USA) freeware program, which uses self-organizing maps (SOMs) to translate high-dimensional data into a 2D mosaic (Eichler et al., 2003). Each tile of the mosaic represents an individual SOM cluster and is color-coded to represent high or low expression of the cluster's genes, thus identifying the underlying pattern. Functional annotation of transcripts was performed using Bibliosphere pathway edition (Genomatix). DNA-microarray data were deposited in the Gene Expression Omnibus (GEO) (GSE118664).
Statistical analysis was performed using GraphPad Prism 6. For analysis of two groups, an unpaired Student's t-test was performed. To compare more than two groups, one-way ANOVA followed by Tukey's post-test was used. All values are presented as mean±s.e.m. P-values ≤0.05 were considered as significant.
We thank Prof. Susan Cotman for providing the Cln3Δex7/8 mice.
Conceptualization: K.D., T.L.; Methodology: K.D., C.M., T.L.; Software: C.M.; Validation: K.D.; Writing - original draft: K.D.; Writing - review & editing: C.M., T.L.; Visualization: K.D., C.M.; Supervision: T.L.; Project administration: T.L.; Funding acquisition: T.L.
This work was supported by the NCL Foundation, the Boll Foundation, the Kämpgen Foundation, the Hans and Marlies Stock Foundation and the Deutsche Forschungsgemeinschaft (DFG FOR2240).
DNA-microarray data are available at GEO under accession number GSE118664.
The authors declare no competing or financial interests.